Efterhånden som der kommer flere centralt godkendte produkter på markedet, øges behovet for opfølgende foranstaltninger, herunder behandling af ændringsansøgninger og effektiv lægemiddelovervågning.
With the increasing support work necessitated by the entry into the market of a growing number of centrally approved products, post-marketing activities including processing of variations (according to numbers forecast) and effective pharmaco-vigilance monitoring are being handled effectively.